Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent combined with surgical delivery system
Reexamination Certificate
1998-09-04
2003-02-04
Thaler, Michael H. (Department: 3731)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent combined with surgical delivery system
C623S001350
Reexamination Certificate
active
06514281
ABSTRACT:
BACKGROUND OF THE INVENTION
The present invention relates to a system for treating vascular disease. More specifically, the present invention relates to a system for deploying a stent in a bifurcation lesion. It is also contemplated that the present invention may be useful in AAA graft delivery.
Vascular disease currently represents a prevalent medical condition. Typical vascular disease involves the development of a stenosis in the vasculature. The particular vessel containing the stenosis can be completely blocked (or occluded) or it can simply be narrowed (or restricted). In either case, restriction of the vessel caused by the stenotic lesion results in many well known problems caused by the reduction or cessation of blood flow through the restricted vessel.
A bifurcation is an area of the vasculature where a first (or parent) vessel is bifurcated into two or more branch vessels. It is not uncommon for stenotic lesions to form in such bifurcations. The stenotic lesions can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels.
Vascular stents are also currently well known. Vascular stents typically involve a tubular stent which is movable from a collapsed, low profile, delivery position to an expanded, deployed position. The stent is typically delivered using a stent delivery device, such as a stent delivery catheter. In one common technique, the stent is crimped down to its delivery position over an expandable element, such as a stent deployment balloon. The stent is then advanced using the catheter attached to the stent deployment balloon to the lesion site under any suitable, commonly known visualization technique. The balloon is then expanded to drive the stent from its delivery position to its deployed position in which the outer periphery of the stent frictionally engages the inner periphery of the lumen. In some instances, the lumen is predilated using a conventional dilatation catheter, and then the stent is deployed to maintain the vessel in an unoccluded, and unrestricted position.
Self-expanding stents can also be used. Self-expanding stents are typically formed of a resilient material. For example, some self-expanding stents are formed of a Nitinol material which is trained to deploy at body temperature. However, other resilient materials can also be used. The resilient material has sufficient resilience that it can be collapsed to the low profile position and inserted within a delivery device, such as a catheter. Once the catheter is placed at the site of the stenotic lesion, the stent is pushed from within the catheter such that it is no longer constrained in its low profile position. The stent, driven by the resilience of the material, expands to a higher profile, deployed position in which its outer periphery frictionally engages the walls of the stenosed vessel, thereby reducing the restriction in the vessel.
While there have recently been considerable advances in stent design and stent deployment techniques, deployment of stents in the treatment of bifurcation lesions remains problematic, particularly where both downstream branch vessels are affected by the lesion. Current techniques of dealing with such lesions typically require the deployment of a slotted tube stent across the bifurcation. However, this compromises the ostium of the unstented branch.
Further, once the first stent is deployed, the treating physician must then advance a dilatation balloon between the struts of the stent already deployed in order to dilate the second branch vessel. The physician may then attempt to maneuver a second stent through the struts of the stent already deployed, into the second branch vessel for deployment. This presents significant difficulties. For example, dilating between the struts of the stent already deployed tends to distort that stent. Further, deploying the second stent through the struts of the first stent is not only difficult, but it can also distort the first stent. Thus, the current systems used to alternately deploy stents in a bifurcated lesion have significant disadvantages.
SUMMARY OF THE INVENTION
A stent deployment system includes a tubular member having a first end and a second end and a generally longitudinal opening between the first and second ends. The tubular member has an inner periphery sized to receive a stent therein. A plurality of apertures are disposed on opposite sides of the generally longitudinal opening. An elongate retainer is removably receivable within the apertures to retain the stent in the tubular member and to release the stent from the tubular member when removed from the apertures.
REFERENCES:
patent: 4730616 (1988-03-01), Frisbie et al.
patent: 4896670 (1990-01-01), Crittenden
patent: 4994071 (1991-02-01), MacGregor
patent: 5019085 (1991-05-01), Hillstead
patent: 5143093 (1992-09-01), Sahota
patent: 5219355 (1993-06-01), Parodi et al.
patent: 5316023 (1994-05-01), Palmaz et al.
patent: 5405378 (1995-04-01), Strecker
patent: 5413581 (1995-05-01), Goy
patent: 5571172 (1996-11-01), Chin
patent: 5591228 (1997-01-01), Edoga
patent: 5607444 (1997-03-01), Lam
patent: 5609627 (1997-03-01), Goicoechea et al.
patent: 5613980 (1997-03-01), Chauhan
patent: 5617878 (1997-04-01), Taheri
patent: 5632762 (1997-05-01), Myler
patent: 5632763 (1997-05-01), Glastra
patent: 5639278 (1997-06-01), Dereume et al.
patent: 5643340 (1997-07-01), Nunokawa
patent: 5669924 (1997-09-01), Shaknovich
patent: 5720735 (1998-02-01), Dorros
patent: 5749825 (1998-05-01), Fischell et al.
patent: 5749890 (1998-05-01), Shaknovich
patent: 5755734 (1998-05-01), Richter et al.
patent: 5755735 (1998-05-01), Richter et al.
patent: 5755770 (1998-05-01), Ravenscroft
patent: 5755771 (1998-05-01), Penn et al.
patent: 5755772 (1998-05-01), Evans et al.
patent: 5755773 (1998-05-01), Evans et al.
patent: 5755778 (1998-05-01), Kleshinski
patent: 5776101 (1998-07-01), Goy
patent: 5782906 (1998-07-01), Marshall et al.
patent: 5797952 (1998-08-01), Klein
patent: 5873906 (1999-02-01), Lau et al.
patent: 5941908 (1999-08-01), Goldsteen et al.
patent: 0 479 730 (1992-04-01), None
patent: 2 678 508 (1993-01-01), None
patent: 0 686 379 (1995-12-01), None
patent: 696447 (1996-02-01), None
patent: WO 9317636 (1993-09-01), None
patent: 95/21592 (1995-08-01), None
patent: WO 96/34580 (1996-11-01), None
patent: WO 96/41592 (1996-12-01), None
patent: WO 97/07752 (1997-03-01), None
patent: WO 97/15346 (1997-05-01), None
patent: WO 97/41803 (1997-11-01), None
patent: WO 98/19628 (1998-05-01), None
patent: WO 9827894 (1998-07-01), None
Blaeser David J.
Mattison Richard C.
Messal Todd P.
Scimed Life Systems Inc.
Thaler Michael H.
LandOfFree
System for delivering bifurcation stents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System for delivering bifurcation stents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System for delivering bifurcation stents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3140800